[Incidents with mild shock symptoms in Wofaverdin tests].
D000328:Adult; D000707:Anaphylaxis / Q000188:drug therapy / Q000209:etiology*; D004396:Coloring Agents / Q000009:adverse effects*; D003486:Cyanides / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000150:complications / Q000188:drug therapy; D004417:Dyspnea / Q000139:chemically induced*; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis; D008297:Male; D010433:Pentylenetetrazole / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D004396:Coloring Agents; D003486:Cyanides; D005947:Glucose; D011241:Prednisone; D010433:Pentylenetetrazole
Zwischenfälle mit leichten Schocksymptomen beim Wofaverdintest.